The safety of our employees is non-negotiable and a top priority for us. We create safety excellence through trainings, risk management and fostering a company-wide safety culture. For us, that means we prioritize a "No Hurt" mindset. A great example is our Atsugi, Japan facility. By creating a culture of safety for all employees, it recently marked 5,000 days without a lost-time injury. Congratulations to the entire team that has actively contributed to the safe work environment.
MilliporeSigma
Biotechnology Research
Burlington, MA 196,864 followers
Together, we impact life and health with science.
About us
Together with our colleagues, customers and stakeholders, we impact life and health with science. Before researchers can make scientific breakthroughs, they must have access to state-of-the-art tools, services and expertise to perform experiments and engineer new products. That’s where we come in. We offer one of the broadest portfolios in the industry for scientists, best-in-class products for pharmaceutical development and manufacturing, and a fully integrated service organization to support CDMO and contract testing across traditional and novel modalities. Our vision is a world where our innovative products, services and digital offerings help create solutions for people globally and a sustainable future for generations to come. The life science business of Merck KGaA, Darmstadt, Germany, operates as MilliporeSigma in the US and Canada. Merck KGaA, Darmstadt, Germany is a global science and technology company with around 60,000 employees in more than 66 countries. Intended only for US/CA visitors.
- Website
-
http://www.sigmaaldrich.com
External link for MilliporeSigma
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Burlington, MA
- Type
- Public Company
- Founded
- 1668
- Specialties
- Life Science Research, Drug Discovery & Development, Lab Filtration, Lab Water, Bioscience, Upstream & Downstream Bioprocessing, BioMonitoring, Lab Solutions, Life Sciences, and Process Solutions
Locations
-
Primary
400 Summit Drive
Burlington, MA 01803, US
Employees at MilliporeSigma
Updates
-
Team Viral Clearance, assemble! Check out how the team tests customers' processes to remove viruses, ensuring drug products are virus-free. Thanks Charmaine Chua, and Muhammad Farith Bin Mubarakh for letting us tag along.
-
We recently announced our largest investment in Asia! Watch how the new Bioprocessing Center that broke ground in Daejeon, South Korea, will support global demand for critical drugs and therapies. Read more about the news here: http://ms.spr.ly/6049l1VDx
-
Our Amicon Ultra Centrifugal filters are ready for a spin 🌀 Join us as we unbox them! Learn more: http://ms.spr.ly/6043lDCx5
-
We have signed a non-binding Memorandum of Understanding with Afrigen Biologics (Pty) Ltd to advance mRNA vaccine technology. Since the program's inception in 2021, our collaboration has successfully improved mRNA vaccine technology production capabilities. Building off of that mutual success, the MoU will focus on enhancing vaccine manufacturing capacity in the region, working together to foster equitable access to life-saving therapies. Learn more here: http://ms.spr.ly/6043lD5N1
-
-
Not all drugs are created equal. Traditional drug tablets are most common, but for children and older adults, they can be difficult to swallow. That's where ODFs or orodispersible films can help. These new drug forms are easier for patients to take because they melt inside the mouth. At our Application Service Lab, scientists like Luna test them with ingredients like excipients and sweeteners to meet the patient's needs. See why she thinks ODFs can be an excellent choice for patients!
-
These cultures are (inter)stellar! The American Society for Microbiology hosts an annual Agar Art Contest featuring art made with living microorganisms. We sponsored last year's event, showcasing products from our Molsheim, France, and Nantong, China, sites. The “Microbiology in Space” submissions are currently on display at our Molsheim, France site as part of our Agar Art Exhibit.
-
Scientists have a powerful weapon in the fight against cancer: highly potent active pharmaceutical ingredients or HPAPIs. These compounds are critical elements in targeted cancer treatment. However, they are famously difficult to handle and manufacture. That’s why we established our new state-of-the-art training center. This center is aimed at equipping/providing our employees with the tools and experience necessary for safe HPAPI production and handling. Watch how we continue to lead in the fight against cancer with our expertise in HPAPIs.